|

Universal CAR-T cells injection for treating HCC and NSCLC Clinical Trials

1 actively recruiting trial

Also known as: REVO-UWD-03

Pipeline

Early 1: 1

Top Sponsors

  • Wondercel Biotech (ShenZhen)1

Indications

  • Liver Disease1
  • NSCLC (Advanced Non-small Cell Lung Cancer)1
  • HCC - Hepatocellular Carcinoma1
  • Liver Cancer1
  • Lung Cancer1

Other1 trial

Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.